D 
Daiichi Sankyo Co 4568.T · JPY
Health Care · Pharmaceuticals · Tokyo Stock Exchange · 🇯🇵 Japan
2,847
+2.89%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in JPY, from our data supplier.
Revenue
¥2.12trn
FY2017FY2026
Net income
¥259.87bn
FY2017FY2026
Free cash flow
−¥50.71bn
FY2017FY2026
Shareholders' equity
¥1.66trn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥2.12trn | ¥1.89trn | ¥1.60trn | ¥1.28trn | ¥1.04trn | ¥962.52bn | ¥981.79bn | ¥929.72bn | ¥960.20bn | ¥955.12bn |
| Gross profit | ¥1.45trn | ¥1.47trn | ¥1.19trn | ¥914.95bn | ¥691.56bn | ¥624.23bn | ¥638.59bn | ¥565.11bn | ¥614.17bn | ¥605.75bn |
| Research and development | ¥466.00bn | ¥436.00bn | ¥365.20bn | ¥341.60bn | ¥260.20bn | ¥227.40bn | ¥197.50bn | ¥203.70bn | ¥236.00bn | ¥214.30bn |
| Operating income | ¥207.31bn | ¥303.29bn | ¥184.20bn | ¥102.16bn | ¥146.05bn | ¥127.59bn | ¥277.60bn | ¥167.41bn | ¥152.56bn | ¥88.93bn |
| Net income | ¥259.87bn | ¥295.76bn | ¥200.73bn | ¥109.19bn | ¥66.97bn | ¥75.96bn | ¥129.07bn | ¥93.41bn | ¥60.28bn | ¥53.47bn |
| Diluted earnings per share | 142.74 | 159.65 | 106.16 | 56.91 | 34.91 | 39.59 | 66.37 | 47.96 | 30.95 | 26.88 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ¥4.01trn | ¥3.46trn | ¥3.46trn | ¥2.51trn | ¥2.22trn | ¥2.09trn | ¥2.11trn | ¥2.09trn | ¥1.90trn | ¥1.91trn |
| Cash and short-term investments | ¥449.81bn | ¥713.97bn | ¥876.56bn | ¥825.13bn | ¥778.62bn | ¥824.91bn | ¥890.71bn | ¥780.03bn | ¥787.08bn | ¥798.95bn |
| Total liabilities | ¥2.34trn | ¥1.83trn | ¥1.77trn | ¥1.06trn | ¥864.87bn | ¥813.13bn | ¥799.35bn | ¥838.35bn | ¥764.71bn | ¥743.55bn |
| Debt | — | ¥155.89bn | ¥156.00bn | ¥192.86bn | ¥213.62bn | ¥226.17bn | ¥266.33bn | ¥261.92bn | ¥282.10bn | ¥282.14bn |
| Shareholders' equity | ¥1.66trn | ¥1.62trn | ¥1.69trn | ¥1.45trn | ¥1.35trn | ¥1.27trn | ¥1.31trn | ¥1.25trn | ¥1.13trn | ¥1.18trn |
| Shares outstanding | 1,821m | 1,853m | 1,891m | 1,919m | 1,919m | 1,919m | 1,945m | 1,948m | 1,948m | 1,989m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ¥77.66bn | ¥53.84bn | ¥599.26bn | ¥114.51bn | ¥139.23bn | ¥192.21bn | ¥196.60bn | ¥92.03bn | ¥108.44bn | ¥136.23bn |
| Capital spending | −¥128.37bn | −¥116.26bn | −¥88.32bn | −¥67.37bn | −¥76.68bn | −¥64.09bn | −¥52.56bn | −¥36.11bn | −¥23.40bn | −¥24.77bn |
| Free cash flow | −¥50.71bn | −¥62.42bn | ¥510.94bn | ¥47.15bn | ¥62.54bn | ¥128.11bn | ¥144.04bn | ¥55.92bn | ¥85.04bn | ¥111.47bn |
| Dividends paid | −¥128.43bn | −¥114.32bn | −¥67.08bn | −¥54.62bn | −¥51.73bn | −¥48.95bn | −¥45.36bn | −¥45.34bn | −¥46.42bn | −¥43.89bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥574.74bn | ¥589.59bn | ¥558.11bn | ¥500.76bn | ¥474.60bn | ¥518.69bn | ¥484.84bn | ¥446.55bn |
| Gross profit | ¥450.45bn | ¥287.15bn | ¥439.83bn | ¥344.77bn | ¥382.25bn | ¥424.35bn | ¥356.46bn | ¥348.52bn |
| Operating income | ¥85.03bn | −¥22.10bn | ¥89.49bn | ¥43.97bn | ¥96.71bn | ¥54.98bn | ¥61.41bn | ¥65.99bn |
| Net income | ¥68.64bn | ¥42.43bn | ¥86.63bn | ¥45.31bn | ¥85.50bn | ¥87.15bn | ¥61.93bn | ¥61.29bn |
| Diluted earnings per share | 37.70 | 23.30 | 46.76 | 24.46 | 46.15 | 47.04 | 32.75 | 32.42 |
| Cash from operations | ¥20.33bn | ¥25.91bn | ¥80.06bn | ¥8.26bn | −¥36.57bn | ¥72.12bn | ¥58.28bn | ¥33.49bn |
| Capital spending | −¥37.24bn | −¥30.41bn | −¥30.67bn | −¥38.57bn | −¥28.72bn | −¥36.41bn | −¥22.98bn | −¥35.70bn |
| Free cash flow | −¥16.90bn | −¥4.50bn | ¥49.38bn | −¥30.31bn | −¥65.29bn | ¥35.71bn | ¥35.30bn | −¥2.21bn |
| Total assets | ¥4.11trn | ¥4.01trn | ¥3.82trn | ¥3.57trn | ¥3.46trn | ¥3.46trn | ¥3.44trn | ¥3.30trn |
| Cash and short-term investments | ¥637.85bn | ¥449.81bn | ¥541.45bn | ¥542.16bn | ¥574.30bn | ¥713.97bn | ¥682.15bn | ¥707.67bn |
| Debt | ¥478.0m | ¥300.48bn | ¥403.0m | ¥201.14bn | ¥100.40bn | ¥116.05bn | ¥401.0m | ¥101.52bn |
| Shareholders' equity | ¥1.70trn | ¥1.66trn | ¥1.71trn | ¥1.65trn | ¥1.58trn | ¥1.62trn | ¥1.62trn | ¥1.62trn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 18.4% | 17.1% | 8.0% |
| Operating income | 26.6% | 10.2% | -2.3% |
| Net income | 33.5% | 27.9% | 12.2% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 72.9% | 72.9% | 71.3% | 68.8% |
| Operating margin | 12.7% | 11.6% | 12.0% | 14.7% |
| Net margin | 13.9% | 12.6% | 11.3% | 10.4% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 20.3 | 21.0 | 41.0 | 68.0 | 121.8 | 73.9 | 53.3 | 50.2 | 37.8 | 36.4 |
| Price to sales | 2.5 | 3.3 | 5.1 | 5.8 | 7.8 | 5.8 | 7.0 | 5.0 | 2.4 | 2.0 |
Dividends and splits
Per share, in the currency the company pays
Paid for 20 years. Last went ex-dividend on 29 Sept 2026.
| FY2027 | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 50.00 | 108.00 | 60.00 | 35.00 | 28.50 | 27.00 | 25.167 | 23.333 |
- 3-for-1 split · 29 Sept 2020
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.